Nuvectis Pharma, Inc. Common Stock (NVCT) is a publicly traded Healthcare sector company. As of August 21, 2026, NVCT trades at $23.45 with a market cap of $760.13M and a P/E ratio of -17.61. NVCT moved +0.56% today. Year to date, NVCT is +176.85%; over the trailing twelve months it is +271.61%. Its 52-week range spans $5.03 to $29.28. Analyst consensus is strong buy with an average price target of $34.00. Rallies surfaces NVCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
4 analysts cover NVCT: 0 strong buy, 4 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $34.00.
| Metric | Value |
|---|---|
| Price | $23.45 |
| Market Cap | $760.13M |
| P/E Ratio | -17.61 |
| EPS | $-1.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $29.28 |
| 52-Week Low | $5.03 |
| Volume | 179.18K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.44M |
| Gross Margin | 0.00% |
4 analysts cover NVCT: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.00.